| Barbara Gabriela Abaroa, CRNA | |
|
6200 Sw 73rd St, South Miami, FL 33143-4679 | |
| (305) 740-0823 | |
| Not Available |
| Full Name | Barbara Gabriela Abaroa |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 11 Years |
| Location | 6200 Sw 73rd St, South Miami, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295155729 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 9281908 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Public Health Trust Of Miami Dade County Florida | 0244380434 | 336 |
News Archive
In a study to be presented on Feb. 6 at 3:15 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report on a correlation between initial neonatal and early childhood outcomes among children delivered less than 34 weeks gestation.
Eli Lilly and Company has announced that the U.S. District Court for the Southern District of Indiana today issued a preliminary injunction to prevent the launch of a generic version of Lilly's medicine Evista (raloxifene HCl tablets) by Teva Pharmaceuticals until the Court renders its final ruling.
Pharmaceutical companies slashed their promotional spending for hormone therapies by more than a third following reports in July 2002 of health risks associated with the drugs, but within the year they beefed up their marketing efforts to promote lower-dose forms of the medications
HemoShear, LLC, a leading developer of innovative, cell-based, human surrogate models for discovery and assessment of new drug compounds, has produced a profile of all of the genes that influence the biology and function of the human artery system. This research has generated valuable information on the entire spectrum of genes that are found in specific cell-types that make up human arteries.
› Verified 2 days ago
| Entity Name | Sheridan Healthcorp Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629781711 PECOS PAC ID: 3173429693 Enrollment ID: O20031208000355 |
News Archive
In a study to be presented on Feb. 6 at 3:15 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report on a correlation between initial neonatal and early childhood outcomes among children delivered less than 34 weeks gestation.
Eli Lilly and Company has announced that the U.S. District Court for the Southern District of Indiana today issued a preliminary injunction to prevent the launch of a generic version of Lilly's medicine Evista (raloxifene HCl tablets) by Teva Pharmaceuticals until the Court renders its final ruling.
Pharmaceutical companies slashed their promotional spending for hormone therapies by more than a third following reports in July 2002 of health risks associated with the drugs, but within the year they beefed up their marketing efforts to promote lower-dose forms of the medications
HemoShear, LLC, a leading developer of innovative, cell-based, human surrogate models for discovery and assessment of new drug compounds, has produced a profile of all of the genes that influence the biology and function of the human artery system. This research has generated valuable information on the entire spectrum of genes that are found in specific cell-types that make up human arteries.
› Verified 2 days ago
| Entity Name | Anesthesia Associates Of Greater Miami, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497700140 PECOS PAC ID: 5294633954 Enrollment ID: O20031219000586 |
News Archive
In a study to be presented on Feb. 6 at 3:15 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report on a correlation between initial neonatal and early childhood outcomes among children delivered less than 34 weeks gestation.
Eli Lilly and Company has announced that the U.S. District Court for the Southern District of Indiana today issued a preliminary injunction to prevent the launch of a generic version of Lilly's medicine Evista (raloxifene HCl tablets) by Teva Pharmaceuticals until the Court renders its final ruling.
Pharmaceutical companies slashed their promotional spending for hormone therapies by more than a third following reports in July 2002 of health risks associated with the drugs, but within the year they beefed up their marketing efforts to promote lower-dose forms of the medications
HemoShear, LLC, a leading developer of innovative, cell-based, human surrogate models for discovery and assessment of new drug compounds, has produced a profile of all of the genes that influence the biology and function of the human artery system. This research has generated valuable information on the entire spectrum of genes that are found in specific cell-types that make up human arteries.
› Verified 2 days ago
| Entity Name | Public Health Trust Of Miami Dade County Florida |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134384423 PECOS PAC ID: 0244380434 Enrollment ID: O20090610000019 |
News Archive
In a study to be presented on Feb. 6 at 3:15 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report on a correlation between initial neonatal and early childhood outcomes among children delivered less than 34 weeks gestation.
Eli Lilly and Company has announced that the U.S. District Court for the Southern District of Indiana today issued a preliminary injunction to prevent the launch of a generic version of Lilly's medicine Evista (raloxifene HCl tablets) by Teva Pharmaceuticals until the Court renders its final ruling.
Pharmaceutical companies slashed their promotional spending for hormone therapies by more than a third following reports in July 2002 of health risks associated with the drugs, but within the year they beefed up their marketing efforts to promote lower-dose forms of the medications
HemoShear, LLC, a leading developer of innovative, cell-based, human surrogate models for discovery and assessment of new drug compounds, has produced a profile of all of the genes that influence the biology and function of the human artery system. This research has generated valuable information on the entire spectrum of genes that are found in specific cell-types that make up human arteries.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Gabriela Abaroa, CRNA 9655 S Dixie Hwy, Suite 201, Miami, FL 33156-2813 Ph: (305) 740-0823 | Barbara Gabriela Abaroa, CRNA 6200 Sw 73rd St, South Miami, FL 33143-4679 Ph: (305) 740-0823 |
News Archive
In a study to be presented on Feb. 6 at 3:15 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report on a correlation between initial neonatal and early childhood outcomes among children delivered less than 34 weeks gestation.
Eli Lilly and Company has announced that the U.S. District Court for the Southern District of Indiana today issued a preliminary injunction to prevent the launch of a generic version of Lilly's medicine Evista (raloxifene HCl tablets) by Teva Pharmaceuticals until the Court renders its final ruling.
Pharmaceutical companies slashed their promotional spending for hormone therapies by more than a third following reports in July 2002 of health risks associated with the drugs, but within the year they beefed up their marketing efforts to promote lower-dose forms of the medications
HemoShear, LLC, a leading developer of innovative, cell-based, human surrogate models for discovery and assessment of new drug compounds, has produced a profile of all of the genes that influence the biology and function of the human artery system. This research has generated valuable information on the entire spectrum of genes that are found in specific cell-types that make up human arteries.
› Verified 2 days ago
Christine R Marambio, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 786-242-4575 | |
Julio David Diaz Morales, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 305-228-4993 | |
Gwendolyn Gail Dorfman, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 786-242-4575 | |
Daniel Gomez, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 6200 Sw 73rd St Fl 2, South Miami, FL 33143 Phone: 305-740-0823 Fax: 305-740-0853 | |
Dennis Luis Diaz, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 305-740-0823 | |
Cristina Carnicer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 786-662-4000 | |
Tyler Shepard, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 786-242-4575 |